CA2220301A1 - Dispositif osmotique avec activation retardee de l'apport d'un medicament et liberation complete du medicament - Google Patents

Dispositif osmotique avec activation retardee de l'apport d'un medicament et liberation complete du medicament

Info

Publication number
CA2220301A1
CA2220301A1 CA002220301A CA2220301A CA2220301A1 CA 2220301 A1 CA2220301 A1 CA 2220301A1 CA 002220301 A CA002220301 A CA 002220301A CA 2220301 A CA2220301 A CA 2220301A CA 2220301 A1 CA2220301 A1 CA 2220301A1
Authority
CA
Canada
Prior art keywords
delivery
drug delivery
osmotic device
active agent
delayed activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002220301A
Other languages
English (en)
Other versions
CA2220301C (fr
Inventor
Liang C. Dong
Patrick S. L. Wong
Si-Hong A. Yum
Lawrence G. Hamel
Michael H. Dealey
Crystal Pollock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corporation
Liang C. Dong
Patrick S. L. Wong
Si-Hong A. Yum
Lawrence G. Hamel
Michael H. Dealey
Crystal Pollock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation, Liang C. Dong, Patrick S. L. Wong, Si-Hong A. Yum, Lawrence G. Hamel, Michael H. Dealey, Crystal Pollock filed Critical Alza Corporation
Priority claimed from PCT/US1996/007933 external-priority patent/WO1996038130A1/fr
Publication of CA2220301A1 publication Critical patent/CA2220301A1/fr
Application granted granted Critical
Publication of CA2220301C publication Critical patent/CA2220301C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
CA002220301A 1995-06-02 1996-05-29 Dispositif osmotique avec activation retardee de l'apport d'un medicament et liberation complete du medicament Expired - Fee Related CA2220301C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45938795A 1995-06-02 1995-06-02
US08/459,387 1995-06-02
US1556796P 1996-04-18 1996-04-18
US60/015,567 1996-04-18
PCT/US1996/007933 WO1996038130A1 (fr) 1995-06-02 1996-05-29 Dispositif osmotique avec activation retardee de l'apport d'un medicament et liberation complete du medicament

Publications (2)

Publication Number Publication Date
CA2220301A1 true CA2220301A1 (fr) 1996-12-05
CA2220301C CA2220301C (fr) 2006-02-21

Family

ID=35929938

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002220301A Expired - Fee Related CA2220301C (fr) 1995-06-02 1996-05-29 Dispositif osmotique avec activation retardee de l'apport d'un medicament et liberation complete du medicament

Country Status (1)

Country Link
CA (1) CA2220301C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113730556A (zh) * 2015-02-09 2021-12-03 安特拉贝欧有限公司 骨质疏松症的治疗

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113730556A (zh) * 2015-02-09 2021-12-03 安特拉贝欧有限公司 骨质疏松症的治疗

Also Published As

Publication number Publication date
CA2220301C (fr) 2006-02-21

Similar Documents

Publication Publication Date Title
ZA93133B (en) Osmotic device with delayed activation of drug delivery.
FR2688422B1 (fr)
NO933239L (fr)
CA2032923A1 (fr) Dispositif d'administration de medicament permettant a la fois une liberation controlee a long terme de la substance medicamenteuse et l'administration d'une dose de mise en charge
WO1996025922A3 (fr) Forme posologique d'agent actif a liberation prolongee en bande
EP1731140A3 (fr) Formulation d'aerosol medicinal
MX9200331A (es) Dispositivo osmotico para surtido retardado de agedispositivo osmotico para surtido retardado de agente. nte.
TW347339B (en) Oral delivery of discrete units
CA2416403A1 (fr) Formulation medicinale d'aerosol
RS49803B (sr) Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa
EP1249229A3 (fr) Libération contrôlée d'un principe actif à l'aide d'un dispositif implantable
PT97203A (pt) Sistema de dosagem osmotica para libertacao de farmacos liquidos
WO1997037640A3 (fr) Traitement par administration uniforme de medicaments
CA2213774A1 (fr) Compositions pharmaceutiques et dispositif permettant leur administration
AU5792796A (en) Osmotic device with high drug loading and delayed activation of drug delivery
AU5883196A (en) Osmotic device with delayed activation of drug delivery and omplete drug release
CA2109698A1 (fr) Dispositif d'administration a long terme, renfermant une dose de charge hydrophobe
CA2220301A1 (fr) Dispositif osmotique avec activation retardee de l'apport d'un medicament et liberation complete du medicament
NZ238867A (en) Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
CA2244997A1 (fr) Administration prolongee d'un agent actif a l'aide d'un systeme implantable
CA2533678A1 (fr) Administration prolongee d'un agent actif a l'aide d'un systeme implantable
CA2249637A1 (fr) Traitement par administration uniforme de medicaments

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140529